umoja-biopharma.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
Meta Tags
Title Umoja
Description Pioneering the future of immunotherapy by reprogramming T cells in Umoja Biopharma pioneering immunotherapy by reprogramming T cells in vivo to target cancer cells and generate lasting
Keywords N/A
Server Information
WebSite umoja-biopharma faviconumoja-biopharma.com
Host IP 104.196.158.64
Location United States
Related Websites
Site Rank
More to Explore
umoja-biopharma.com Valuation
US$17,740,592
Last updated: 2023-05-07 09:47:22

umoja-biopharma.com has Semrush global rank of 596,615. umoja-biopharma.com has an estimated worth of US$ 17,740,592, based on its estimated Ads revenue. umoja-biopharma.com receives approximately 2,046,992 unique visitors each day. Its web server is located in United States, with IP address 104.196.158.64. According to SiteAdvisor, umoja-biopharma.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$17,740,592
Daily Ads Revenue US$16,376
Monthly Ads Revenue US$491,278
Yearly Ads Revenue US$5,895,336
Daily Unique Visitors 136,467
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
umoja-biopharma.com. A 599 IP: 104.196.158.64
umoja-biopharma.com. NS 3600 NS Record: ns60.domaincontrol.com.
umoja-biopharma.com. NS 3600 NS Record: ns59.domaincontrol.com.
umoja-biopharma.com. MX 3600 MX Record: 0 umojabiopharma-com01c.mail.protection.outlook.com.
umoja-biopharma.com. TXT 3600 TXT Record: v=spf1 include:spf.protection.outlook.com -all
umoja-biopharma.com. TXT 3600 TXT Record: smartsheet-site-validation=Cf96Xewoc2eSCNs97GIvgBcz6LU7rap6
umoja-biopharma.com. TXT 3600 TXT Record: v=verifydomain MS=5649095
umoja-biopharma.com. TXT 3600 TXT Record: docusign=56a5e651-5b0b-4bbc-a1b0-d5d154d1340d
umoja-biopharma.com. TXT 3600 TXT Record: spycloud-domain-verification=3f294c7e-d23f-4041-aaf7-7eff78b9139a
umoja-biopharma.com. TXT 3600 TXT Record: google-site-verification=uEHJRMUVSqjo8oBHkVMRzIVVR9oqr_H8i0nEctMwKmE
HtmlToTextCheckTime:2023-05-07 09:47:22
Our Company Menu Toggle Leadership Board of Directors Advisory Board Our Team Investors Our Science Menu Toggle Overview Manufacturing Partnerships Our Pipeline News + Resources Menu Toggle Press Releases In The Media Blog White Papers Presentations + Publications Careers Contact Our Company Menu Toggle Our Team Our Science Menu Toggle Overview Manufacturing Partnerships Our Pipeline News + Resources Menu Toggle Press Releases In The Media Blog White Papers Presentations Careers Contact Main Menu Our Company Menu Toggle Our Team Our Science Menu Toggle Overview Manufacturing Partnerships Our Pipeline News + Resources Menu Toggle Press Releases In The Media Blog White Papers Presentations Careers Contact Accessibility Privacy Policy Transparency in Coverage Sitemap Pioneering the future of immunotherapy by reprogramming T cells in vivo Our groundbreaking integrated platform therapeutics reprogram the immune system in the patient’s body to target cancer cells and generate lasting
HTTP Headers
HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Wed, 27 Oct 2021 19:14:15 GMT
Content-Type: text/html
Content-Length: 162
Connection: keep-alive
Keep-Alive: timeout=20
Location: https://umoja-biopharma.com/

HTTP/2 301 
server: nginx
date: Wed, 27 Oct 2021 19:14:15 GMT
content-type: text/html; charset=UTF-8
content-length: 0
location: https://www.umoja-biopharma.com/
x-redirect-by: WordPress
x-powered-by: WP Engine
x-cacheable: non200
cache-control: max-age=600, must-revalidate
x-cache: HIT: 1
x-cache-group: normal

HTTP/2 200 
server: nginx
date: Wed, 27 Oct 2021 19:14:16 GMT
content-type: text/html; charset=UTF-8
content-length: 40284
vary: Accept-Encoding
vary: Accept-Encoding
link: ; rel="https://api.w.org/"
link: ; rel="alternate"; type="application/json"
link: ; rel=shortlink
x-powered-by: WP Engine
x-cacheable: SHORT
vary: Accept-Encoding,Cookie
cache-control: max-age=600, must-revalidate
x-cache: HIT: 3
x-cache-group: normal
accept-ranges: bytes
umoja-biopharma.com Whois Information
Domain Name: UMOJA-BIOPHARMA.COM
Registry Domain ID: 2392763902_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2021-05-12T21:14:35Z
Creation Date: 2019-05-19T21:13:03Z
Registry Expiry Date: 2022-05-19T21:13:03Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS59.DOMAINCONTROL.COM
Name Server: NS60.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-15T14:54:13Z <<<